FIELD: anti-inflammatory drugs.
SUBSTANCE: invention relates to the use of 4-(4-bromophenyl)-2-[2-(4-nitrobenzoyl)hydrazono]-4-oxobutanoic acid of formula 1 as a drug with anti-inflammatory activity.
EFFECT: pronounced anti-inflammatory activity and low toxicity of 4-(4-bromophenyl)-2-[2-(4-nitrobenzoyl)hydrazono]-4-oxobutanoic acid were revealed.
1 cl, 1 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| 2-(2-(4-NITROBENZOYL)HYDRAZONO)-4-OXO-4-PHENYLBUTANOIC ACID 4-METHYLBENZYL ETHER WITH ANTI-INFLAMMATORY ACTIVITY | 2022 |
|
RU2798431C1 |
| 1-(4-METHOXYPHENYL)2-(2-(4-NITROBENZOYL)HYDRASONO)-4-OXO-4-(4-METHYLPHENYL)BUTANOIC ACID ETHYL ETHER WITH ANTI-INFLAMMATORY ACTIVITY | 2022 |
|
RU2798428C1 |
| 2-((3-CYANO-4,5,6,7-TETRAHYDROBENZO[b]THIOPHEN-2-yl)AMINO)-4-(4-METHOXYPHENYL)-4-OXOBUT-2-ENOIC ACID WITH ANTI-INFLAMMATORY ACTIVITY | 2022 |
|
RU2784434C1 |
| N-(5-BROMOPYRIDIN-2-YL)-4-OXO-4-(P-TOLYL)-2-((3-CYANO-4,5,6,7-TETRAHYDROBENZO[B]THIOPHEN-2-YL) )AMINO)BUT-2-ENAMIDE AS AN ANTI-INFLAMMATORY DRUG | 2022 |
|
RU2798426C1 |
| APPLICATION OF 2-[(3-(AMINOCARBONIL)-4,5,6,7-TETRAHYDROBENZO[b]THIOPHEN-2-yl)AMINO]-4-OXO-4-(4-CHLOROPHENYL)BUT-2-ENOIC ACID IN AS AN ANTI-INFLAMMATORY DRUG | 2022 |
|
RU2785780C1 |
| 1-AMINO-1,6-DIOXO-6-(4-CHLOROPHENYL)-2-CYANO-4-(3-CYANO-4,5,6,7-TETRAHYDROBENZO[B]THIOPHEN-2-YL)AMINO)HEXA -2,4-DIEN-3-OLATE POTASSIUM WITH ANTI-INFLAMMATORY ACTIVITY | 2022 |
|
RU2798468C1 |
| APPLICATION OF N-(2-OXO-5-(4-CHLOROPHENYL)FURAN-3(2H)-YLYDENE)-4-NITROBENZOHYDRAZIDE AS AN ANTI-INFLAMMATORY DRUG | 2022 |
|
RU2785782C1 |
| APPLICATION OF 2-(2-(4-NITROBENZOYL)HYDRASONO)-4-OXO-4-(THIOPHENE-2-YL)BUTANOIC ACID AS AN ANALGESIC DRUG | 2022 |
|
RU2785786C1 |
| 2-(2-(4-NITROBENZOYL)HYDRASONO)-4-OXO-4-(4-METHYLPHENYL)BUTANOIC ACID OCTYL ETHER WITH ANALGESIC ACTIVITY | 2022 |
|
RU2798427C1 |
| 4-(4-BROMOPHENYL)-4-OXO-2-{[3-ETHOXYCARBONYL)-4,5-DIMETHYLTHIEN-2-YL]AMINO}-2-BUTENOIC ACID, HAVING ANTI-INFLAMMATORY AND ANALGESIC ACTIVITY | 2012 |
|
RU2485112C1 |
